In the present study, we investigated whether a gross deletion in the nef gene (g∆nef) is induced by Korean red ginseng (KRG) intake. Ten patients were treated with KRG powder for 3 years in the absence of antiretroviral drug therapy. On average, 3,555 ± 1,042 g KRG was administered per person over 36.1±2.4 months. There was a mild decrease in CD4 T cell count (75 ± 110/mL) over the 36.1±2.4 months (p = 0.059). We obtained 355 nef amplicons using 71 peripheral blood mononuclear cell samples over a 3-year period. All ten patients exhibited g∆nef (range, 3.2 to 45.9%). At baseline, 3 of 78 amplicons (3.8%) exhibited g∆nef, whereas 18.8% (52/277) revealed g∆nef during KRG-intake (p < 0.001). The proportion of g∆nef was significantly correlated with monthly dose of KRG (r = 0.89, p < 0.001). The median time for first detection of g∆nef was 13 months. In conclusion, our data show that g∆nef is inducible by KRG intake and its proportion is dependent on the duration of KRG intake and dose of KRG.
INTRODUCTION
Gross deletions or genetic defects in the human immunodeficiency virus (HIV)-1 gene in HIV-1 infected patients are very rare [1] [2] [3] . Thus, it is known that genetic defects may not be a common characteristics among long-term nonprogressors (LTNPs)/long-term survivors (LTS) or elite controllers. However, gross deletions in the nef gene (g∆nef) have been reported in many LTNPs [4, 5] . However, limitations in most of these studies, such as small patient numbers or absence of appropriate control groups, have hindered interpretation of results [6] . Highly active antiretroviral therapy (HAART) has reduced mortality and morbidity related to human immunodeficiency virus diseases [7] . However, treatment with all antiretroviral agents selects for drug-resistant mutations in the HIV-1 gene that ultimately result in therapy failure. To my knowledge, there is no report that describes any treatments that attenuate HIV-1 (or other) viruses.
Panax ginseng C. A. Meyer has been used as a drug for more than 2,000 years [8] . Recently, many reports put a high value on ginseng as immune modulator and adjuvant [9, 10] . In 1991, we began treating HIV-1 infected patients with Korean red ginseng (KRG) for 6 months and observed that KRG-intake had various beneficial effects, including increases in CD4 and CD8 T cell counts [11] [12] [13] . We subsequently reported that KRG slows depletion of CD4 T cells in HIV-1-infected patients over 10 years [14] [15] [16] [17] . We also showed that there was a high frequency of g∆nef in LTS [18] and hemophiliacs [19] that had been treated with KRG; in this latter group, there was a dose-dependent relationship between KRG intake and the frequency of g∆nef. In ad-dition, the frequency of a gross deletion in the 5'-LTR/ gag in these KRG-treated patients was 2-fold higher than that of the g∆nef [20] . With KRG treatment alone, several patients among less than 100 HIV-1 infected patients diagnosed prior to 1991 remained healthy for 20 years after diagnosis [20, 21] , and we recently showed that combined treatment with HAART plus KRG was more beneficial than HAART only [22] .
However, despite demonstrating a strong association between the occurrence of g∆nef and KRG intake, our previous study was unable to define the time at which the first gross deletion occurred during KRG intake due to the absence of baseline data and samples collected prior to 3 years after initiating KRG intake [18, 19] . In the present study, we investigated the time to first occurrence of a g∆nef in ten patients for whom baseline and/or earlier samples were available. Our data show that g∆nef is inducible in all patients within 30 months of KRG intake and its proportion depends on the duration and dosage of KRG intake.
MATERIALS AND METHODS

Study population
Among our cohort, ten patients infected with subtype B of HIV-1 and treated with KRG were selected. Inclusion criteria were consistent intake of KRG for up to 3 years and availability of at least five samples for 3 years in the absence of HAART. We excluded hemophiliacs because these patients were infected with HIV-1 through a different mode of transmission [23] . Patients infected with non-subtype B were also excluded. All patients were diagnosed between 1989 and 2004 (Table   1 ). Except 2 patients (95-87 and 96-51), they had not taken KRG prior to this study. Eight patients were male and two were female. Informed written consent was obtained from all subjects before the initiation of the study.
Therapy with Korean red ginseng
KRG treatment in HIV-1-infected patients was begun on an outpatient basis at the Korean National Institute of Health in late 1991 [11, 12] . The daily dose of KRG was 5.4 g for men and 2.7 g for women [22] . On averfor men and 2.7 g for women [22] . On averfor men and 2.7 g for women [22] . On aver-2.7 g for women [22] . On averg for women [22] . On averfor women [22] . On averfor women [22] . On aver- [22] . On aver-. On averOn averOn average, 3,555 ± 1,042 g KRG was administered over the course of 36.1 ± 2.4 months.
CD4 T cell counts and plasma HIV-1 RNA copy numbers
Blood was drawn from each patient at 3-to 6-month intervals, and peripheral blood mononuclear cells (PBMCs) in each sample were incubated with phycoerythrin-and fluorescein isothiocyanate-conjugated antibodies (combined in the Simultest reagent; Becton Dickinson, San Jose, CA, USA) against CD4 and CD8 antigens, respectively. Levels of CD4 and CD8 T cells were measured by flow cytometry using FACScan (Becton Dickinson). Plasma concentrations of HIV-1 RNA were measured using the Amplicor HIV-1 Monitor kit (Roche Diagnostics, Branchburg, NJ, USA) [16] .
Amplification of the nef gene
Proviral DNA was extracted from uncultured PBMCs. nef amplicons were amplified from each sample by double-nested (rarely, triple-nested) PCR as described elsewhere [18, 19] . http://ginsengres.org
HLA typing
DNA was isolated from PBMC and HLA-A, -B, and -C typing was performed using the amplification-refractory mutation system-PCR method. Each tube contained a primer mix consisting of the allele-or groupspecific primer pairs, as well as a plus control primer matching the nonallelic sequences. There were 32 sets specific for HLA-A, 27 sets for HLA-B, and 23 sets for HLA-C. Details are described elsewhere [16] .
Statistical analysis
Data are expressed as means±standard deviations. Statistical significance was estimated by Student's twotailed t-test, the chi-square test, Fisher's exact test, or correlation analysis, using SPSS ver. 12.0 (SPSS Inc., Chicago, IL, USA). Statistical significance was defined as p < 0.05.
Nucleotide sequences
GenBank accession numbers are HM369809-920, HM369933-040, AY121476, AY221717, DQ121935-948, AY121479, AY221649, AY363353-354, HM369962-970, HM747120, HM747122-123, HM747126-128, HM747130, HM747133, and HM747135-136.
RESULTS
Viral load and CD4 T cells
In the eight patients in whom plasma viral RNA copy number was determined (P24 antigen was measured in the remaining two patients) [24] , there was a significant correlation between plasma viral RNA level and the decrease in CD4 T cells (r = 0.87, p < 0.01). In four of eight patients, viral RNA copy number was measured at both baseline and endpoints. In three patients, the changes (1,470 to 9,400 copies/mL, 44,000 to 30,730 copies/ mL, and 22,100 to 34,839 copies/mL) were not signifi -L, and 22,100 to 34,839 copies/mL) were not signifi -, and 22,100 to 34,839 copies/mL) were not signifi -L) were not signifi -) were not significant. However, in one patient with a high baseline level of viral RNA (530,000 copies/mL), viral copy number increased to 4,755,746 copies/mL over the course of 33 months in association with a continuous decrease in CD4 T cell count from 450/mL to 190/mL. This steep decrease in CD4 T cell might be associated with homozygotes at 3 alleles of HLA class I (A24,-B35,-Cw9, -) and the worst prognosis allele B35 [25, 26] (Table 2) .
Relationship between Korean red ginseng intake and change in CD4 T cells
On average, patients consumed 3,555±1,042 g KRG (range, 1,512 to 5,520 g) over a time span of 36.1 ± 2.4 months. The average monthly dose was 101 ± 25 g (range, 63 to 154 g). Although there was a trend toward a decrease in CD4 T cell count (from 398 ± 154/mL to 323 ± 146/mL) over the duration of the trial, this corresponds to annual decrease of 24/mL (p = 0.059).
Higher frequency of nef gene after KRG intake compared to baseline
Including 10 samples at baseline or prior to KRG intake, we collected 71 PBMC samples over 36.1±2.4 months from patients on KRG intake for PCR analysis of the g∆nef. Four reactions for each sample were at- (Fig. 1) .
Median time for the detection of first nef gene
All ten patients exhibited g∆nef during KRG intake, with a median time for first detection of g∆nef of 13 months (range, 0 to 29 months) ( Table 2 ). The locations and sizes of gross deletion are described in Table 3 .
Correlation between nef gene proportion, and dose and duration of KRG intake
The proportion of gross deletions as a percent of amplicons was variable among patients (3.2% to 45.9%). The patient (92-48) who revealed the highest proportion took the highest dosage of KRG. He was followed up to 53 months after the end of this study. Overall 50 amplicons were obtained during KRG intake and 25 were grossly deleted (50%), whereas there was one g∆nef among 11 amplicons before KRG intake (1/11) (p < 0.05). There was a significant relationship between the monthly amount of KRG intake and the proportion of g∆nef (r = 0.89, p < 0.001) (Fig. 2) . To determine whether the proportion of g∆nef was related to the duration of KRG intake, we divided all 355 PCR amplicons into three 12-month groups (baseline, 1 to 12 months, 13 to 24 months, and 25 to 36 months) according to the duration of KRG intake.
Importantly, we found that the proportion of g∆nef increased with increasing duration of KRG intake (p < 0.01); g∆nef proportion was 3.8% (3/78) at baseline, 9.6% (7/73) at 1 to 12 months, 20.4% (19/93) at 13 to 24 months, and 23.4% (26/111) at 25 to 36 months (Fig. 3) .
No premature stop codon in the nef gene
We determined sequences of 140 wild type nef out of 295 amplicons obtained during KRG intake. There was no premature stop codon or G-to-A hypermutations. However, in patient 01-99, all sequences revealed deletion of 9 base pairs of 9th-11th amino acids from the initiation codon.
DISCUSSION
Previous report showed that KRG slows depletion of CD4 T cells in HIV type 1-infected patients. In addition, our studies over the last 10 years have indicated a strong association between KRG intake and gross deletion in the g∆nef [18, 19, 21] . However, these previous reports have suffered from important limitations, including lack of baseline and earlier samples within 3 years after initiating KRG intake. Thus, although we were able to establish that the occurrence of g∆nef depends on the amount of KRG intake [19] , we could not determine the relationship between the duration of KRG intake and the detection of g∆nef.
In the present study, we focused on the first 3 years of KRG intake. Considering a sampling interval of about 6 months, the median time for the detection of g∆nef might be less than the 13 months estimated here. In any case, g∆nef occurs considerably earlier than the median time 67-month of our previous study [18] .
Among the three patients who revealed g∆nef at baseline, patient 01-99 was infected with HIV-1 through her husband, who was diagnosed with HIV-1 infection in 1987 and had taken KRG since 1994, suggesting that the wife's g∆nef might have resulted from previous virus exposure to KRG. The husband, who has remained healthy in the absence of HAART for 22 years, did not reveal g∆nef at baseline [20] , but did have a high proportion of gross deletion in 5'-LTR/gag [20] . Our data show that a high frequency of gΔnef is directly associated with KRG intake rather than host factors or introduction of a genetically defective HIV-1 strain in Korea.
Regarding prognosis, except one patient 04-397 with the worst HLA allele, all patients show relative good prognosis. In detail, 91-22 who had been infected with HIV via transfusion in December 1989 remains healthy for 20 years in the absence of HAART. After this study Despite the association between KRG intake and g∆nef we do not know the mechanism for the nef deletions. In the same patients, the proportion with gross deletion in 5'LTR/gag was 23.1% during KRG intake (data not shown). In addition, G-to-A hypermutations in the vif and pol genes are significantly high during KRG intake (data not shown). In other words, the g∆nef is not the only gene affected by KRG intake. It seems that whole HIV-1 genes are nonspecifically affected by KRG intake [13, 20, 21] . Therefore, we can speculate that both direct antiviral and indirect immunological mechanisms are involved together with decrease in chronic immune activation in CTL function [12, 16, 17] . With respect to the antiretroviral effects of ginseng, several reports also support our data. It is known that several ginsenosides including polyacetyleneginsenoside-Ro from Panax ginseng and xylanase from Panax notoginseng inhibited the replication of HIV-1 [27] [28] [29] . In addition, it is known that ginsenosides Rb1, Rb2, Rb3, and Rc have anti-HIV replication in vitro (patent, CN1745756A).
Regarding immunological mechanism, it seems that gΔnef might indirectly result from the enhancement of innate immunity than adaptive immunity [30] [31] [32] , immune modulation toward Th1-cytokines [33, 34] , antiinflammatory response through TLR4 induced NFkB [35] as well as the attenuation of hyper-immune activation state [12, 16] . In particular, it appears that the LTR region including gΔnef is more fragile to KRG intake than are other regions of HIV-1 because HIV-1 gene expression is modulated by cis-acting regulatory elements in the LTRs [36] . In addition, approximately 200 substances, such as ginsenoside, polysaccharides, polyacetylenes, peptides, and amino acids, have been isolated from Korean ginseng [37] . Therefore, it might not be easy to elucidate the mechanism. Through this study, we confirmed that g∆nef is inducible by KRG intake although future study is required whether the g∆nef is caused by ginsenosides or polysaccharide. 
Fig. 3.
Relationship between the duration of Korean red ginseng intake and the proportion of nef gene (g∆nef). The proportion of g∆nef was 3.8% at baseline, 9.6% at 1 to 12 months, 20.4% at 13 to 24 months, and 23.4% at 25 to 36 months (p < 0.01).
